- Patients
- Clinical Research
- Clinical trials
- OCEANiC
2024-06-18T12:20:57.351Z
OCEANiC
OCEANiC
Lung cancer
A study on the effect of Osimertinib, with or without Adjuvant Chemotherapy, Guided by Tumour Next Generation Sequencing (NGS) Co-mutation Status and circulating tumour DNA (ctDNA) Detection on disease-free survival in Patients with Stage IIA-IIIA epidermal growth factor receptor (EGFR)-Mutant Non-Small Cell Lung Cancer Following Complete Surgical Resection
A study on the effect of Osimertinib, with or without Adjuvant Chemotherapy, Guided by Tumour Next Generation Sequencing (NGS) Co-mutation Status and circulating tumour DNA (ctDNA) Detection on disease-free survival in Patients with Stage IIA-IIIA epidermal growth factor receptor (EGFR)-Mutant Non-Small Cell Lung Cancer Following Complete Surgical Resection
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Lung cancer
Study Phase
II
Trial registration
Number: ACTRN12623000552684
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=375560
GenesisCare Location(s)
GenesisCare North Shore
GenesisCare North Shore
:::
Principal Investigator(s)